MAGNANI, GAIA
 Distribuzione geografica
Continente #
NA - Nord America 1.708
EU - Europa 1.318
AS - Asia 1.015
AF - Africa 82
SA - Sud America 65
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.189
Nazione #
US - Stati Uniti d'America 1.694
SG - Singapore 355
CN - Cina 314
GB - Regno Unito 296
DE - Germania 207
IT - Italia 201
SE - Svezia 195
VN - Vietnam 138
UA - Ucraina 102
HK - Hong Kong 89
RU - Federazione Russa 76
IE - Irlanda 63
IN - India 59
FR - Francia 51
BR - Brasile 49
NL - Olanda 28
FI - Finlandia 25
ZA - Sudafrica 25
JO - Giordania 24
TG - Togo 24
BG - Bulgaria 22
EE - Estonia 21
JP - Giappone 20
BE - Belgio 11
NG - Nigeria 11
SC - Seychelles 11
AR - Argentina 10
CH - Svizzera 9
CA - Canada 8
CI - Costa d'Avorio 7
IR - Iran 6
MX - Messico 5
LT - Lituania 3
PL - Polonia 3
BD - Bangladesh 2
CL - Cile 2
GR - Grecia 2
KR - Corea 2
MA - Marocco 2
AE - Emirati Arabi Uniti 1
AZ - Azerbaigian 1
CZ - Repubblica Ceca 1
EG - Egitto 1
EU - Europa 1
ID - Indonesia 1
LB - Libano 1
NO - Norvegia 1
PE - Perù 1
PY - Paraguay 1
RO - Romania 1
SV - El Salvador 1
TN - Tunisia 1
TR - Turchia 1
TW - Taiwan 1
UY - Uruguay 1
VE - Venezuela 1
Totale 4.189
Città #
Southend 259
Singapore 232
Ashburn 181
Fairfield 178
Chandler 133
Hong Kong 89
Wilmington 88
Woodbridge 88
Seattle 81
Houston 80
Princeton 75
Santa Clara 74
Cambridge 65
Dublin 63
Ann Arbor 61
Jacksonville 58
Beijing 49
Boardman 46
New York 43
Nanjing 35
Bremen 31
Padova 31
Westminster 31
Bologna 29
Ho Chi Minh City 25
Amman 24
Lomé 24
Berlin 23
Helsinki 23
Los Angeles 22
Shenyang 22
Sofia 22
Dong Ket 21
Turin 20
Tokyo 19
Jinan 18
Buffalo 17
Dallas 17
Medford 17
Mülheim 16
Changsha 13
Frankfurt am Main 13
Hebei 12
Saint Petersburg 12
Abeokuta 11
Brussels 10
Dearborn 10
Hanoi 10
San Diego 10
Guangzhou 9
Hefei 9
Jiaxing 9
Munich 9
Kuban 8
Nanchang 8
Redondo Beach 8
São Paulo 8
Abidjan 7
Falkenstein 7
Rome 7
Shanghai 7
Tianjin 7
Verona 7
Yubileyny 7
Bern 6
Florence 6
Mahé 6
Milan 6
Parma 6
Redmond 6
San Venanzo 6
Taizhou 6
Ancona 5
Des Moines 5
Haikou 5
Redwood City 5
Reggio Emilia 5
Taiyuan 5
Zhengzhou 5
Chicago 4
Haiphong 4
Kunming 4
Olalla 4
Boston 3
Council Bluffs 3
Hangzhou 3
Merano 3
Mexico City 3
Nuremberg 3
Ravenna 3
Bari 2
Calgary 2
Carrara 2
Catania 2
Concordia 2
Denver 2
Düsseldorf 2
Frankfurt Am Main 2
Fuzhou 2
Hortolândia 2
Totale 2.788
Nome #
Changes in exercise capacity induced by heart transplantation: prognostic and therapeutic implications. 222
Le complicanze metaboliche post-trapianto di cuore ruolo dell'adiponectina ed associazione con la malattia coronarica del graft 182
Prognostic implications of serial assessments of pulmonary hypertension in severe chronic heart failure. 170
Cyclosporine lowering with everolimus versus mycophenolate mofetil in heart transplant recipients: Long-term follow-up of the SHIRAKISS randomized, prospective study. 154
Safety and efficacy of early aggressive versus cholesterol-driven lipid-lowering strategies in heart transplantation: A pilot, randomized, intravascular ultrasound study. 153
Differential effect of everolimus on progression of early and late cardiac allograft vasculopathy in current clinical practice. 150
Clinical and Prognostic Correlates of pAMR Grading in Patients with Suspect Antibody Mediated Rejection 149
Cyclosporine lowering with everolimus or mycophenolate to preserve renal function in heart recipients: a randomized study. 144
Hydroxymethyl-glutaryl coenzyme a reductase inhibition limits cytomegalovirus infection in human endothelial cells. 143
Interplay of coronary angiography and intravascular ultrasound in predicting long-term outcomes after heart transplantation 142
Prophylaxis versus preemptive therapy for prevention of the consequences of cytomegalovirus infection in transplant recipients: a still unresolved issue 139
Prophylaxis versus preemptive anti-cytomegalovirus approach for prevention of allograft vasculopathy in heart transplant recipients 138
Prophylaxis vs. Pre-Emptive Strategies in Preventing Cytomegalovirus-Dependent Cardiac Allograft Vasculopathy 136
PRE-TRANSPLANT NON-CYTOTOXIC ANTI-HLA ANTIBODIES PREDICT MULTIPLE ADVERSE EVENTS AFTER HEART TRANSPLANTATION 136
Differential Effect of Everolimus and Metabolic Risk Factors on Early vs. Late Progression of Allograft Vasculopathy: Dissecting Two Faces of the Same Disease 135
Efficacia e sicurezza dell'ezetimibe in associazione con basse dosi di simvastatina per il trattamento dell'iperlipidemia post-trapianto cardiaco 134
Reproducibility of IVUS Measurements in Heart Transplant Recipients: Increased Quality of Data by Using Dedicated Software for Image Analysis 134
Ruolo dell'NT-proBNP nella stratificazione prognostica dei pazienti con scompenso cardiaco cronico. 133
Differential Effects of Everolimus on Early vs. Late Allograft Vasculopathy Progression in Heart Transplant Recipients: a Longitudinal IVUS-Based Study 132
PREDICTING CARDIOVASCULAR OUTCOMES LONG-TERM AFTER HEART TRANSPLANT BY LATE CHANGES IN MAXIMAL INTIMAL THICKNESS: BEYOND THE HYSTORICAL 1-YEAR LIMIT 132
EVEROLIMUS REDUCES CAV PROGRESSION AS COMPARED WITH AZATHIOPRINE AND MYCOPHENOLATE: A LONGITUDINAL IVUS- BASED STUDY 132
Il rallentamento del flusso di perfusione coronarica valutato con il TIMI frame count è in grado di predire la mortalità a lungo termine nei pazienti con trapianto di cuore 129
Pre-Transplant Non-Cytotoxic Anti-HLA Antibodies Predict Multiple Adverse Events after Heart Transplantation 129
L'infezione da citomegalovirus e i parametri indicativi di insulino-resistenza influenzano in modo distinto e specifico le variazioni nella geometria coronarica nel primo anno dopo trapianto di cuore 127
Interplay between Pulmonary Hypertension and Donor-Recipient Matching in the Risk for Early Graft Failure after Heart Transplantation 123
Late Changes in Maximal Intimal Thickness after Heart Transplant: Prognostic Implications and Risk Factors 118
Potential of medical treatment, device therapy, and conventional surgery in patients referred for heart transplantation. 116
Relevance of cardioverter defibrillators for the prevention of sudden cardiac death on the timing of heart transplantation. 116
Coronary allograft vasculopathy: pathophysiological interaction between the immune system, infections and metabolic syndrome 115
Safety and efficacy of ezetimibe with low doses of simvastatin in heart transplant recipients. 113
Role of Donor-Recipient Match in Determining the Risk for Primary Graft Failure after Heart Transplantation 98
Totale 4.274
Categoria #
all - tutte 11.272
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.272


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021222 0 0 0 0 0 15 9 14 33 26 12 113
2021/2022578 24 14 34 86 51 27 8 40 20 69 110 95
2022/2023677 71 98 40 85 58 56 14 25 123 26 59 22
2023/2024177 15 36 3 20 2 68 4 2 0 8 8 11
2024/2025640 38 123 57 60 109 33 37 18 1 37 12 115
2025/2026636 118 94 104 72 186 62 0 0 0 0 0 0
Totale 4.274